Zobrazeno 1 - 10
of 404
pro vyhledávání: '"anti-TB drugs"'
Autor:
Jadhav, Krishna a, Jhilta, Agrim a, Singh, Raghuraj a, d, Sharma, Shweta b, Negi, Swarnima a, Ahirwar, Kailash c, Shukla, Rahul c, Singh, Amit Kumar b, d, 1, ∗∗, Verma, Rahul Kumar a, d, ⁎, 1
Publikováno v:
In Journal of Controlled Release 10 February 2025 378:671-686
Publikováno v:
Scripta Score Scientific Medical Journal, Vol 5, Iss 2, Pp 156-164 (2024)
Background: Tuberculosis (TB) is a treatable infectious disease caused by the Mycobacterium tuberculosis pathogen. However, patient non-compliance during treatment contributes to the emergence of Multidrug-resistant Tuberculosis (MDR-TB). This litera
Externí odkaz:
https://doaj.org/article/22f8699e833b447bb1693c88c1aa1df1
Publikováno v:
Risk Management and Healthcare Policy, Vol Volume 16, Pp 1955-1965 (2023)
Meng Zhou,1 Ying Peng,2 Kui Liu,2 Lin Zhou,2 Fei Wang,2 Xinyi Chen,2 Bin Chen,2,3,* Chonggao Hu2,* 1Department of Social Medicine of School of Public Health, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of C
Externí odkaz:
https://doaj.org/article/124677599c73443d881d29e9790eb2f7
Autor:
Ahmad Khalid Madadi, Moon-Jun Sohn
Publikováno v:
Pharmaceutics, Vol 16, Iss 4, p 540 (2024)
Tuberculous meningitis (TBM) presents a critical neurologic emergency characterized by high mortality and morbidity rates, necessitating immediate therapeutic intervention, often ahead of definitive microbiological and molecular diagnoses. The primar
Externí odkaz:
https://doaj.org/article/3772a7164a8a41aeb65835020b5fce35
Publikováno v:
Metabolites, Vol 14, Iss 1, p 63 (2024)
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a significant global health challenge, further compounded by the issue of antimicrobial resistance (AMR). AMR is a result of several system-level molecular rearrangements enabling
Externí odkaz:
https://doaj.org/article/5a61c2f1870c43e3a67741bab8299953
Autor:
Kassech Sintayehu, Eden Dagnachew Zeleke, Busha Temesgen, Meron Kifle, Dawit Getachew Assefa, Kibebew Zenebe, Ashenafi Kassahun, Ben Tegegn Yimer
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background The health sectors success has been determined by consistent and reasonably priced health commodities supply. Despite possible death from the disease, Tuberculosis (TB) can be prevented with early diagnosis and appropriate treatme
Externí odkaz:
https://doaj.org/article/c9ed518d7f4844db8a4280dd9add3215
Publikováno v:
Journal of Pre-Clinical and Clinical Research, Vol 16, Iss 2, Pp 34-37 (2022)
Introduction and objective Loss to follow-up (LTFU) along the TB care cascade is a barrier to TB control because of sustained TB transmission including resistant strains, high mortality and increased spread of DRTB strains. Understanding common reaso
Externí odkaz:
https://doaj.org/article/743367db03434a3faa129e61728a7d50
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jan-Willem C. Alffenaar, Jurriaan E. M. de Steenwinkel, Andreas H. Diacon, Ulrika S. H. Simonsson, Shashikant Srivastava, Sebastian G. Wicha
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
There has been an increased interest in pharmacokinetics and pharmacodynamics (PKPD) of anti-tuberculosis drugs. A better understanding of the relationship between drug exposure, antimicrobial kill and acquired drug resistance is essential not only t
Externí odkaz:
https://doaj.org/article/e4542944f8a243b7ad22068ab5e9346d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.